• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Aravis Ventures

edit

Aravis Ventures is a financial organisation which targets its investments in the fields of life sciences and renewable energy. Their investments are focused in Europe, Asia and North America.

Recent Milestones

edit

• 
  Aravis Ventures invested in Telormedix. (2/28/12)
  Posted 1/10/12 at 8:12pm via onbiovc.com
• 
  Aravis Ventures invested in Synosia Therapeutics. (10/12/10)
  Posted 10/20/10 at 10:55pm via synosia.com
• 
  Aravis Ventures invested in MerLion Pharmaceuticals. (10/11/10)
  Posted 10/11/10 at 7:15pm via onbiovc.com
• 
  Aravis Ventures invested in Evolva. (12/7/09)
  Posted 10/28/09 at 7:50am via onbiovc.com
• 
  Aravis Ventures invested in NovImmune. (5/12/09)
  Posted 6/17/09 at 1:31pm via onbiovc.com
• 
  Aravis Ventures invested in Ambrx. (4/1/09)
  Posted 4/13/09 at 1:07pm via onbiovc.com
• 
  Aravis Ventures invested in Synosia Therapeutics. (1/1/09)
  Posted 5/20/09 at 2:28pm via fiercebiotech.com
• 
  Aravis Ventures invested in S*Bio. (10/20/08)
  Posted 6/18/09 at 4:35pm
• 
  Aravis Ventures invested in Omeros. (2/12/07)
  Posted 4/19/10 at 8:15pm via omeros.com
• 
  Aravis Ventures invested in Borean Pharma. (3/23/05)
  Posted 7/5/10 at 4:12am via bioportfolio.com

Investments

Videos

Sources

1. Telormedix, SA.: Series B $8.3M (onbiovc.com) [edit]
2. Synosia Therapeutics Raises $30M in Series C Financing (synosia.com) [edit]
3. MerLion Pharmaceuticals Pte. Ltd.: Series C $7M (onbiovc.com) [edit]
4. Evolva, SA: Series B $27.5M (onbiovc.com) [edit]
5. NovImmune, SA: Series C $54.8M (onbiovc.com) [edit]
6. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
7. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
8. Capital Report Index [edit]
9. Omeros Raises More Than $63 Million in Financing (investor.omeros.com) [edit]
10. Borean Pharma raises Euros 4 Million in series A fundraising (bioportfolio.com) [edit]